| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/06/2000 | WO2000000625A1 Methods for production of recombinant polypeptides |
| 01/06/2000 | WO2000000622A2 Human oxidoreductase proteins |
| 01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
| 01/06/2000 | WO2000000611A2 14273 receptor, a g-protein coupled receptor |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
| 01/06/2000 | WO2000000606A1 Npy-y7 receptor gene |
| 01/06/2000 | WO2000000602A1 Novel gaba-b receptor |
| 01/06/2000 | WO2000000592A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 01/06/2000 | WO2000000591A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000219A1 Remedies for hypercalcemic crisis |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999047661A3 Production of biofilaments in transgenic animals |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1998001460A8 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/06/2000 | CA2332379A1 Molecules associated with apoptosis |
| 01/06/2000 | CA2332128A1 Therapeutic agent for hypercalcemic crisis |
| 01/06/2000 | CA2331887A1 Novel gaba-b receptor |
| 01/06/2000 | CA2331886A1 14273 receptor, a g-protein coupled receptor |
| 01/06/2000 | CA2331762A1 Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2331380A1 Human oxidoreductase proteins |
| 01/06/2000 | CA2331328A1 Npy-y7 receptor gene |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/06/2000 | CA2301024A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 01/05/2000 | EP0969092A1 Rice gene resistant to blast disease |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
| 01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
| 01/05/2000 | EP0968295A1 Vectors having enhanced expression and methods of making and uses thereof |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968289A1 Icam-6 materials and methods |
| 01/05/2000 | EP0968288A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968285A1 Morphogenic proteins |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/05/2000 | EP0641357B1 Hiv protein epitopes immunologically homologous to hla |
| 01/05/2000 | DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein |
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
| 01/04/2000 | US6011137 Fusion proteins |
| 01/04/2000 | US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents |
| 01/04/2000 | US6010903 Anti-human ceruloplasmin monoclonal antibody |
| 01/04/2000 | US6010902 Complex useful in controlling lymphocytes |
| 01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
| 01/04/2000 | US6010893 Process for producing human matrilysin by means of recombinant DNA |
| 01/04/2000 | US6010886 Receptor for oncostatin M |
| 01/04/2000 | US6010885 Expression of heterologous polypeptides in halobacteria |
| 01/04/2000 | US6010884 Recombinant binding proteins and peptides |
| 01/04/2000 | US6010883 Recombinant fusion proteins |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
| 01/04/2000 | US6010871 Modification of peptide and protein |
| 01/04/2000 | US6010865 Process for detecting a variant CD44 gene product |
| 01/04/2000 | US6010861 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 01/04/2000 | US6010844 Methods of preparing and recovering proteins |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | CA2093145C Substantially pure interleukin-9 receptor and uses thereof |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA2005478C Method for solubilization and naturation of somatotropin |
| 01/04/2000 | CA1340869C T cell activation markers |
| 01/04/2000 | CA1340867C Expression plasmids for improved production of heterologus protein in bacteria |
| 12/30/1999 | DE19828377A1 A transgenic non-human mammal expressing immunoglobulin E heavy chain, useful for testing of anti-human IgE antibodies |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067377A1 Human arf-related proteins |
| 12/29/1999 | WO1999067360A2 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067356A2 Propionibacterium vector |
| 12/29/1999 | WO1999067289A1 A method for inducing production of growth factors |
| 12/29/1999 | WO1999067282A2 Olfactory receptors and their uses |
| 12/29/1999 | WO1999066956A1 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
| 12/29/1999 | WO1999058647A3 Human deadenylating nuclease, its production and its use |
| 12/29/1999 | WO1999058563A3 Moraxella catharralis proteins |
| 12/29/1999 | WO1999043802A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 12/29/1999 | WO1999041390A8 Expression vector for the production of dead proteins |
| 12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
| 12/29/1999 | EP0967285A1 Prolylendopeptidase from Flavobacterium meningosepticum |
| 12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| 12/29/1999 | EP0967278A2 Flowering regulating gene and its use |
| 12/29/1999 | EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 12/29/1999 | EP0967276A2 Anti-tumor agent comprising salmosin |
| 12/29/1999 | EP0967275A1 Dna sequences enhancing promoter activity |
| 12/29/1999 | EP0967226A2 Methods for the production of fibrillar collagen |
| 12/29/1999 | EP0966971A1 Cerebral stroke/cerebral edema preventive or remedy containing il-8 binding inhibitor as active ingredient |
| 12/29/1999 | EP0966541A1 Method and constructs for inhibiting protein expression in bacteria |
| 12/29/1999 | EP0966536A1 Factor x analogues with a modified protease cleavage site |
| 12/29/1999 | EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii) |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966521A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide |